Reuters logo
BRIEF-Glenmark Pharmaceuticals gets ANDA approval for propafenone hydrochloride extended-release capsules USP
September 11, 2017 / 3:19 AM / 2 months ago

BRIEF-Glenmark Pharmaceuticals gets ANDA approval for propafenone hydrochloride extended-release capsules USP

Sept 11 (Reuters) - Glenmark Pharmaceuticals

* Says co receives ANDA approval for propafenone hydrochloride extended-release capsules USP, 225 mg, 325 mg, and 425 mg Source text - bit.ly/2ePWYfs Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below